iCanADAPT Early protocol: randomised controlled trial (RCT) of clinician supervised transdiagnostic internet-delivered cognitive behaviour therapy (iCBT) for depression and/or anxiety in early stage cancer survivors -vs- treatment as usual
Open Access
- 15 March 2017
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 17 (1) , 193
Abstract
This RCT with two parallel arms will evaluate the efficacy of an internet-delivered transdiagnostic cognitive behavioural therapy (iCBT) intervention for the treatment of clinical depression and/or anxiety in early stage cancer survivors. Early stage cancer survivors will be recruited via the research arm of a not-for-profit clinical research unit and randomised to an intervention (iCBT) group or a ‘treatment as usual’ (TAU) control group. The minimum sample size for each group is 45 people (assuming effect size > 0.6, power of 80%, and alpha at .05), but 10% more will be recruited to account for attrition. A solitary or cumulative diagnosis(es) of Major Depressive Episode (current), Generalised Anxiety Disorder, Illness Anxiety Disorder, Panic Disorder, Agoraphobia, and/or Adjustment disorder will be determined using modules from the Anxiety Disorders Interview Schedule for DSM-5. Depression and anxiety levels with be measured via the total score of the Hospital Anxiety and Depression scale (HADS-T), the primary outcome measure. Secondary measures will include the Kessler 10 to measure general distress, the Fear of Cancer Recurrence Inventory (FCRI) to measure the specific fear of cancer recurrence and the Functional Assessment of Cancer Therapy, General Version 4 (FACT-G) for self-report of physical, social, emotional and functional well-being. iCBT participants will complete the measures before lessons 1 and 5, at post-treatment and at 3-month follow-up. The TAU group will complete similar measures at weeks 1, 8 and 16 of the waiting period. Program efficacy will be determined using intent-to-treat mixed models. Maintenance of gains will be assessed at 3-month follow-up. Mediation analyses using PROCESS will be used to examine the association between change in depressive and anxious symptoms over time and changes in FCRI and FACT-G QOL in separate analysis. This is the first RCT looking at iCBT specifically for clinical depression and/or anxiety in a cancer population. Findings will help to direct the role of iCBT in streamlined psycho-social care pathways. Australian New Zealand Clinical Trials Registry: ACTRN12616000231448, registered 19th February 2016 ( www.anzctr.org.au ). This trial protocol is in compliance with the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines.Keywords
Funding Information
- Cancer Institute NSW (ID 14/TPG/1-02)
- National Health and Medical Research Council (Early Career Australian Clinical Fellowship 1037797, Senior Principal Research Fellowship)
- New South Wales Institute of Psychiatry (Research Fellow)
This publication has 53 references indexed in Scilit:
- ‘I know they are distressed. What do I do now?’Psycho-Oncology, 2013
- Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and ageJournal of Affective Disorders, 2012
- Predicting Fear of Breast Cancer Recurrence and Self-Efficacy in Survivors by Age at DiagnosisOncology Nursing Forum, 2012
- Internet interventions for improving psychological well‐being in psycho‐oncology: review and recommendationsPsycho-Oncology, 2011
- Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendationsAnnals of Oncology, 2011
- Computer Therapy for the Anxiety and Depressive Disorders Is Effective, Acceptable and Practical Health Care: A Meta-AnalysisPLOS ONE, 2010
- Hospital anxiety and depression scale cutoff scores for cancer patients in acute careBritish Journal of Cancer, 2009
- Internet‐based mental health programs: A powerful tool in the rural medical kitAustralian Journal of Rural Health, 2007
- Psychosocial Interventions for Depression, Anxiety, and Quality of Life in Cancer Survivors: Meta-AnalysesThe International Journal of Psychiatry in Medicine, 2006
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983